Analyst Ratings and Financial Health of Gilead Sciences, Inc. (NASDAQ:GILD)

"(GILD) Earns "Hold" Rating from Maxim Group" was first posted by TrueBlueTribune and is the property of of TrueBlueTribune. The stock has "Buy" rating by Oddo & Cie on Tuesday, August 16. Leerink Swann maintained the shares of GILD in report on Thursday, October 19 with "Market Perform" rating. After $2.51 actual earnings per share reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts -17.53% negative EPS growth. Out of 20 total analysts who were surveyed, 1 rated it a Moderate Buy, 10 rated it hold, and 9 rated it a Strong Buy. Redburn Partners started coverage on Gilead Sciences in a research note on Wednesday, July 26th. The rating was upgraded by Societe Generale to "Buy" on Wednesday, May 18. Cowen and Company set a $120.00 price target on Gilead Sciences and gave the company a buy rating in a research report on Sunday, October 23rd. 73,333 shares were sold by MARTIN JOHN C, worth $4.78 million on Thursday, June 1.

The company's stock is now moving with a +ve distance from the 200 day SMA of approximately 7.13%, and has a solid year to date (YTD) performance of 7.62% which means that the stock is constantly adding to its value from the previous fiscal year end price. Clifford Swan Investment Counsel Llc sold 5,947 shares as Gilead Sciences Inc (GILD)'s stock declined 8.05%. The stock increased 2.53% or $0.11 on October 27, reaching $4.46. The firm has a market capitalization of $99.37 billion, a PE ratio of 8.26 and a beta of 1.14.

For the Current Quarter, the growth estimate for Gilead Sciences -32.2%, while for the Next Quarter the stock growth estimate is -15.7%.

The Stock had a 1.94 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2 and 2.12 respectively. Gilead Sciences had a net margin of 42.22% and a return on equity of 57.15%.

Analysts are also projecting an Average Revenue Estimate for Gilead Sciences $5.79 Million in the Current Quarter.

Quarterly Earnings Growth on year-over-year basis stands at -9.6 percent.

EVP, CFO, Washington Robin L, sold 51,820 common shares of Gilead Sciences, Inc. S&Co has invested 0.06% in Gilead Sciences, Inc. (NASDAQ:GILD). Natixis has 739,347 shares. If you are viewing this story on another site, it was stolen and republished in violation of USA and worldwide trademark and copyright legislation.

Nikko Asset Management Americas Inc. raised its holdings in shares of Gilead Sciences, Inc.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 28th. (NASDAQ:GILD). Geode Cap Management Lc invested in 0.42% or 15.09 million shares. As per Thursday, December 1, the company rating was downgraded by Guggenheim.

After a recent scan, we can see that Gilead Sciences, Inc. The Accuvest Global Advisors holds 7,852 shares with $556,000 value, down from 16,138 last quarter. 07, 2017, the shares were put up for sale at an average price of $85, raking in a sum of $4,404,700. Following the transaction, the chief financial officer now directly owns 43,352 shares in the company, valued at approximately $3,684,920. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Another trade for 9,943 shares valued at $668,667 was made by Cogan John Francis on Tuesday, May 9. The stock was sold at an average price of $75.86, for a total value of $5,563,041.38. Amer Mgmt owns 41,000 shares. The disclosure for this sale can be found here. In the last ninety days, insiders sold 446,819 shares of company stock worth $36,338,919. The stock was sold at an average price of $81.97, for a total value of $286,895.00.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Parnassus Investments CA increased its position in shares of Gilead Sciences by 37.4% in the first quarter. Muhlenkamp & Co Inc bought 200,985 shares as the company's stock declined 8.05% while stock markets rallied.

According to Suncor Energy Inc.'s Insider ownership is at 0.04%. Jacobs Levy Equity Mngmt Inc holds 0.47% or 312,654 shares. FMR LLC grew its position in Gilead Sciences by 1.1% in the 2nd quarter. The stock decreased 1.04% or $0.81 on October 27, reaching $77.07.

Gilead Sciences, Inc is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The recent change has given its price a -4.55% deficit over SMA 50 and -10.66% deficit over its 52-week high.

Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Earnings Yield for Gilead Sciences, Inc. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions.

Like this


31 October 2017
Com Premium features arrive for Office 365 subscribers
Please be aware that the rollout is now underway worldwide for those with Office 365 Home and Office 365 Personal subscriptions. Microsoft is also including better malware scanning security, and free technical support for Outlook .com email accounts.

31 October 2017
Centre geared up to end terror: Rajnath Singh
Sameer Aslam Shaikh received the Prime Minister's Baton and Home Minister's Revolver for the best all-around IPS probationer. Rajnath also announced the Ministry of Home Affairs (MHA) will provide an amount of Rs 5 Crore to Academy's welfare society.

31 October 2017
Trump names suspect captured for role in 2012 Benghazi attack on Americans
It's not initially clear whether the video shows al-Imam at the consulate or the annex which was also attacked. Three other USA officials, Glen Doherty, Sean Smith, and Tyrone Woods, were also killed.

30 October 2017
PS4 Owners Can Play Monster Hunter World as Aloy; Beta Date Confirmed
And the PS4 exclusive announcements didn't end here, as the company also revealed a beta for the game starting on December 9. The first of these offers a look at the three quest missions that will be included in the beta.

30 October 2017
North Korea flies balloons to Seoul with message 'Trump is mentally ill'
Trump will be in South Korea on November 7 and the United States has already dispatched three nuclear-powered aircraft carriers to the area.

30 October 2017
Kuwait PM submits cabinet's resignation after minister questioned
The Emir accepted the resignation and ordered that the ministers will now take on a caretaker role until a new cabinet is formed. Prime Minister Sabah has held his post since 2011 and was reappointed after the parliamentary election the following year.

30 October 2017
Securities Analyst Recommendations: TRI Pointe Group, Inc. (TPH), Mellanox Technologies, Ltd. (MLNX)
The fund owned 457,757 shares of the construction company's stock after purchasing an additional 60,434 shares during the quarter. Finally, Meeder Asset Management Inc. purchased a new stake in shares of TRI Pointe Group in the 3rd quarter valued at $923,000.

30 October 2017
We won't shut down Al-Jazeera, says Qatar emir
On the efforts to resolve the Gulf crisis, the emir pointed out that he is more than willing to sit down with his antagonists. Doha rejected all the demands, denouncing them as attempts to infringe Qatar's sovereignty. "We do not support terrorism".

30 October 2017
Bethenny Frankel Freaks Out As Beloved Dog Has Seizure For 45 Minutes
My poor daughter and I are watching my dog have a seizure for 45 minutes and the [vet] hospital's so far out. Unfortunately, Cookie experienced two more seizures during the evening on October 29.

30 October 2017
Harvey Weinstein offered Rose McGowan USD 1M to keep quiet
Oscar winners Angelina Jolie, Gwyneth Paltrow, and Mira Sorvino all said that they had unwanted advances from Weinstein. Now that so many women are coming out with their Harvey Weinstein accusations, she chose to speak out.